These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16609064

  • 1. Lenalidomide therapy in myelofibrosis with myeloid metaplasia.
    Tefferi A, Cortes J, Verstovsek S, Mesa RA, Thomas D, Lasho TL, Hogan WJ, Litzow MR, Allred JB, Jones D, Byrne C, Zeldis JB, Ketterling RP, McClure RF, Giles F, Kantarjian HM.
    Blood; 2006 Aug 15; 108(4):1158-64. PubMed ID: 16609064
    [Abstract] [Full Text] [Related]

  • 2. Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.
    Quintás-Cardama A, Kantarjian HM, Manshouri T, Thomas D, Cortes J, Ravandi F, Garcia-Manero G, Ferrajoli A, Bueso-Ramos C, Verstovsek S.
    J Clin Oncol; 2009 Oct 01; 27(28):4760-6. PubMed ID: 19720904
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improvement of the hematologic toxicities of ruxolitinib in patients with MPN-associated myelofibrosis using a combination of thalidomide, stanozolol and prednisone.
    Duan M, Zhou D.
    Hematology; 2019 Dec 01; 24(1):516-520. PubMed ID: 31242816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
    Marchetti M, Barosi G, Balestri F, Viarengo G, Gentili S, Barulli S, Demory JL, Ilariucci F, Volpe A, Bordessoule D, Grossi A, Le Bousse-Kerdiles MC, Caenazzo A, Pecci A, Falcone A, Broccia G, Bendotti C, Bauduer F, Buccisano F, Dupriez B.
    J Clin Oncol; 2004 Feb 01; 22(3):424-31. PubMed ID: 14752066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A phase-2 trial of low-dose pomalidomide in myelofibrosis.
    Begna KH, Mesa RA, Pardanani A, Hogan WJ, Litzow MR, McClure RF, Tefferi A.
    Leukemia; 2011 Feb 01; 25(2):301-4. PubMed ID: 21052089
    [Abstract] [Full Text] [Related]

  • 9. A case of myelofibrosis with myeloid metaplasia with JAK2(V617F) mutation who developed fibrous tumours in multiple organs.
    Tabuchi T, Ohashi H, Fukami S, Susaki N, Kunishima S, Yokozawa T, Nagai H, Moritani S, Ichihara S, Saito H, Hamaguchi M.
    Eur J Haematol; 2006 Sep 01; 77(3):264-6. PubMed ID: 16923114
    [No Abstract] [Full Text] [Related]

  • 10. Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.
    Mesa RA, Elliott MA, Schroeder G, Tefferi A.
    Mayo Clin Proc; 2004 Jul 01; 79(7):883-9. PubMed ID: 15244384
    [Abstract] [Full Text] [Related]

  • 11. Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions.
    Tefferi A, Lasho TL, Mesa RA, Pardanani A, Ketterling RP, Hanson CA.
    Leukemia; 2007 Aug 01; 21(8):1827-8. PubMed ID: 17460705
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thalidomide and lenalidomide in primary myelofibrosis.
    Holle N, de Witte T, Mandigers C, Schaap N, Raymakers R.
    Neth J Med; 2010 Aug 01; 68(1):293-8. PubMed ID: 20739725
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis.
    Burgstaller S, Fridrik M, Hojas S, Kühr T, Ludwig H, Mayrbäurl B, Pöhnl R, Pötscher M, Schlögl E, Zauner D, Thaler J, Gisslinger H.
    Wien Klin Wochenschr; 2013 Apr 01; 125(7-8):196-9. PubMed ID: 23536018
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.